[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK

H Adler, S Gould, P Hine, LB Snell, W Wong… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7

B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira… - Cell reports, 2021 - cell.com
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …

[HTML][HTML] Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized …

YM Arabi, A Alothman, HH Balkhy, A Al-Dawood… - Trials, 2018 - Springer
Background It had been more than 5 years since the first case of Middle East Respiratory
Syndrome coronavirus infection (MERS-CoV) was recorded, but no specific treatment has …

[HTML][HTML] Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia

YM Arabi, AH Hajeer, T Luke… - Emerging infectious …, 2016 - ncbi.nlm.nih.gov
We explored the feasibility of collecting convalescent plasma for passive immunotherapy of
Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to …

[HTML][HTML] Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a …

Y Arabi, H Balkhy, AH Hajeer, A Bouchama… - Springerplus, 2015 - Springer
Abstract As of September 30, 2015, a total of 1589 laboratory-confirmed cases of infection
with the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to …

Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission

PJ Lillie, A Samson, A Li, K Adams… - Journal of …, 2020 - journalofinfection.com
In this Journal, Zhu et al. recently reported the results of their genomic analysis of multidrug-
resistant Klebsiella pneumoniae isolates from individual patients before and after colistin …

Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study

O Stirrup, J Blackstone, F Mapp, A MacNeil, M Panca… - Elife, 2022 - elifesciences.org
Background: Viral sequencing of SARS-CoV-2 has been used for outbreak investigation, but
there is limited evidence supporting routine use for infection prevention and control (IPC) …

[HTML][HTML] COVID-19 management in a UK NHS foundation trust with a high consequence infectious diseases centre: A retrospective analysis

KF Baker, AT Hanrath, I Schim van der Loeff, SA Tee… - Medical …, 2021 - mdpi.com
Recent large national and international cohorts describe the baseline characteristics and
outcome of hospitalised patients with COVID-19, however there is limited granularity to …

[HTML][HTML] Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab …

Y Taha, H Wardle, AB Evans, ER Hunter, H Marr… - Annals of clinical …, 2021 - Springer
Background There is growing evidence that antibody responses play a role in the resolution
of SARS-CoV-2 infection. Patients with primary or secondary antibody deficiency are at …

[HTML][HTML] Genetic variants of APOL1 are major determinants of kidney failure in people of African ancestry with HIV

RKY Hung, E Binns-Roemer, JW Booth, R Hilton… - Kidney International …, 2022 - Elsevier
Introduction Variants of the APOL1 gene are associated with chronic kidney disease (CKD)
in people of African ancestry, although evidence for their impact in people with HIV are …